tradingkey.logo

STRATA Skin Sciences Inc

SSKN
1.270USD
+0.050+4.10%
Close 12/24, 13:00ETQuotes delayed by 15 min
6.69MMarket Cap
LossP/E TTM

STRATA Skin Sciences Inc

1.270
+0.050+4.10%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of STRATA Skin Sciences Inc

Currency: USD Updated: 2025-12-24

Key Insights

STRATA Skin Sciences Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 123/206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 7.40.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

STRATA Skin Sciences Inc's Score

Industry at a Glance

Industry Ranking
123 / 206
Overall Ranking
291 / 4562
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 2 analysts
Strong Buy
Current Rating
7.400
Target Price
+436.23%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

STRATA Skin Sciences Inc Highlights

StrengthsRisks
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
Growing
The company is in a growing phase, with the latest annual income totaling USD 33.56M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 33.56M.
Overvalued
The company’s latest PE is -0.48, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 2.60M shares, decreasing 6.19% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 101.53K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 16.43.

Financial Health

Currency: USD Updated: 2025-12-24

The current financial score of STRATA Skin Sciences Inc is 6.66, ranking 139/206 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 6.93M, representing a year-over-year decrease of 21.23%, while its net profit experienced a year-over-year decrease of 23.56%.

Score

Industry at a Glance

Previous score
6.66
Change
0

Financials

5.74

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

6.50

Operational Efficiency

7.78

Growth Potential

6.19

Shareholder Returns

7.11

STRATA Skin Sciences Inc's Company Valuation

Currency: USD Updated: 2025-12-24

The current valuation score of STRATA Skin Sciences Inc is 7.23, ranking 110/206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.48, which is -6.31% below the recent high of -0.45 and -1620.39% above the recent low of -8.32.

Score

Industry at a Glance

Previous score
7.23
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 123/206
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-24

The current earnings forecast score of STRATA Skin Sciences Inc is 9.00, ranking 6/206 in the Healthcare Equipment & Supplies industry. The average price target for STRATA Skin Sciences Inc is 7.40, with a high of 10.80 and a low of 4.00.

Score

Industry at a Glance

Previous score
9.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 2 analysts
Strong Buy
Current Rating
7.400
Target Price
+436.23%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

90
Total
4
Median
7
Average
Company name
Ratings
Analysts
STRATA Skin Sciences Inc
SSKN
2
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
34
Veeva Systems Inc
VEEV
34
Intuitive Surgical Inc
ISRG
34
Thermo Fisher Scientific Inc
TMO
27
1
2
3
...
18

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-24

The current price momentum score of STRATA Skin Sciences Inc is 4.59, ranking 188/206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 1.47 and the support level at 1.13, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
3.95
Change
0.64

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.010
Sell
RSI(14)
42.489
Neutral
STOCH(KDJ)(9,3,3)
20.389
Neutral
ATR(14)
0.088
High Vlolatility
CCI(14)
-77.999
Neutral
Williams %R
75.758
Sell
TRIX(12,20)
-0.697
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
1.238
Buy
MA10
1.307
Sell
MA20
1.368
Sell
MA50
1.534
Sell
MA100
1.699
Sell
MA200
2.077
Sell

Institutional Confidence

Currency: USD Updated: 2025-12-24

The current institutional shareholding score of STRATA Skin Sciences Inc is 3.00, ranking 135/206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 49.33%, representing a quarter-over-quarter decrease of 27.48%. The largest institutional shareholder is James Simons, holding a total of 101.53K shares, representing 1.72% of shares outstanding, with 29.37% decrease in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Accelmed Growth Partners Management Ltd
1.44M
--
22NW, LP
537.00K
--
Nantahala Capital Management, LLC
403.92K
--
Lincoln Alternative Strategies LLC
365.85K
--
Renaissance Technologies LLC
Star Investors
98.03K
-3.73%
The Vanguard Group, Inc.
Star Investors
84.63K
--
Azzad Asset Management, Inc.
12.00K
+9.09%
Geode Capital Management, L.L.C.
18.19K
-0.42%
MGO One Seven LLC
17.14K
--
1
2

Risk Assessment

Currency: USD Updated: 2025-12-24

The current risk assessment score of STRATA Skin Sciences Inc is 1.25, ranking 192/206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.29. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
1.25
Change
0
Beta vs S&P 500 index
0.29
VaR
+7.36%
240-Day Maximum Drawdown
+60.13%
240-Day Volatility
+141.37%

Return

Best Daily Return
60 days
+41.56%
120 days
+52.35%
5 years
+61.81%
Worst Daily Return
60 days
-12.44%
120 days
-33.57%
5 years
-33.57%
Sharpe Ratio
60 days
-1.23
120 days
-0.17
5 years
-0.21

Risk Assessment

Maximum Drawdown
240 days
+60.13%
3 years
+91.05%
5 years
+93.83%
Return-to-Drawdown Ratio
240 days
-0.95
3 years
-0.33
5 years
-0.20
Skewness
240 days
+2.51
3 years
+2.22
5 years
+2.25

Volatility

Realised Volatility
240 days
+141.37%
5 years
+119.22%
Standardised True Range
240 days
+14.76%
5 years
+44.90%
Downside Risk-Adjusted Return
120 days
-33.05%
240 days
-33.05%
Maximum Daily Upside Volatility
60 days
+158.59%
Maximum Daily Downside Volatility
60 days
+96.08%

Liquidity

Average Turnover Rate
60 days
+23.90%
120 days
+12.14%
5 years
--
Turnover Deviation
20 days
+1643.31%
60 days
+512.23%
120 days
+210.96%

Peer Comparison

Healthcare Equipment & Supplies
STRATA Skin Sciences Inc
STRATA Skin Sciences Inc
SSKN
5.89 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
Edwards Lifesciences Corp
EW
8.69 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
Artivion Inc
AORT
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
Tactile Systems Technology Inc
TCMD
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of STRATA Skin Sciences Inc?

The TradingKey Stock Score provides a comprehensive assessment of STRATA Skin Sciences Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of STRATA Skin Sciences Inc’s performance and outlook.

How do we generate the financial health score of STRATA Skin Sciences Inc?

To generate the financial health score of STRATA Skin Sciences Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects STRATA Skin Sciences Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of STRATA Skin Sciences Inc.

How do we generate the company valuation score of STRATA Skin Sciences Inc?

To generate the company valuation score of STRATA Skin Sciences Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare STRATA Skin Sciences Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of STRATA Skin Sciences Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of STRATA Skin Sciences Inc.

How do we generate the earnings forecast score of STRATA Skin Sciences Inc?

To calculate the earnings forecast score of STRATA Skin Sciences Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on STRATA Skin Sciences Inc’s future.

How do we generate the price momentum score of STRATA Skin Sciences Inc?

When generating the price momentum score for STRATA Skin Sciences Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of STRATA Skin Sciences Inc’s prices. A higher score indicates a more stable short-term price trend for STRATA Skin Sciences Inc.

How do we generate the institutional confidence score of STRATA Skin Sciences Inc?

To generate the institutional confidence score of STRATA Skin Sciences Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about STRATA Skin Sciences Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of STRATA Skin Sciences Inc.

How do we generate the risk management score of STRATA Skin Sciences Inc?

To assess the risk management score of STRATA Skin Sciences Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of STRATA Skin Sciences Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of STRATA Skin Sciences Inc.
KeyAI